Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Aspira Women's Health Inc. | c617-20170106xex99_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K/A
(Amendment No. 1)CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported): January 6, 2017
Vermillion, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware |
001-34810 |
33-0595156 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (512) 519-0400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Explanatory Note
This Amendment No. 1 to Form 8-K (this “Form 8-K/A”) is an amendment to the Current Report on Form 8-K, originally filed by Vermillion, Inc. with the Securities and Exchange Commission on January 6, 2017 (the “Original Report”). Vermillion, Inc. is filing this Form 8-K/A solely to correct the date of report indicated on the cover page of the Original Report and on the signature page of the Original Report.
Item 7.01. Regulation FD Disclosure.
A copy of the investor presentation that Vermillion, Inc. plans to use in conjunction with meetings, beginning on January 9, 2017, during the J.P. Morgan Healthcare Conference is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01Financial Statements and Exhibits.
(d) Exhibit No.Description.
99.1Vermillion, Inc. investor presentation dated January 9, 2017
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Vermillion, Inc. |
|
Date: January 6, 2017 |
By:/s/ Eric J. Schoen |
|
|
Name: Eric J. Schoen |
|
|
Title: Senior Vice President, Finance and Chief Accounting Officer |
EXHIBITS INDEX
Exhibit No.Description
99.1Vermillion, Inc. investor presentation dated January 2017